Business description: Bio-Techne Corporation

Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows:

- biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.;

- diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ;

- other (0.4%).

Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).

Number of employees: 3,100

Sales by Activity: Bio-Techne Corporation

Fiscal Period: June20202021202220232024

Protein Sciences

555M 705M 832M 846M 831M

Diagnostics and Spatial Biology

185M 228M 275M 293M 326M

Other Revenue

- - - - 4.15M

Intersegment Revenue

-1.21M -1.28M -1.56M -1.65M -2.39M
See all business segments

Geographical breakdown of sales: Bio-Techne Corporation

Fiscal Period: June20202021202220232024

United States

404M 502M 614M 642M 658M

EMEA, Excluding United Kingdom

155M 204M 219M 220M 241M

Greater China

68.79M 87.56M 112M 114M 99.47M

APAC, Excluding Greater China

60.36M 69.01M 76.14M 73.19M 73.9M

United Kingdom

30.41M 40.94M 48.64M 49.46M 50.01M

Rest of World

19.43M 27.17M 35.22M 37.49M 36.5M
See all geographic segments

Managers: Bio-Techne Corporation

Director TitleAgeSince
Chief Executive Officer 58 2024-01-31
Director of Finance/CFO 54 2014-03-31
Investor Relations Contact - 2019-09-30
Corporate Officer/Principal 56 2024-01-07
General Counsel 50 2023-03-02
See BIO-TECHNE CORPORATION governance

Members of the board: Bio-Techne Corporation

Manager TitleAgeSince
Chairman 69 2012-11-01
Director/Board Member 55 2009-05-18
Director/Board Member 62 2017-10-25
Director/Board Member 72 2017-10-25
Director/Board Member 60 2019-06-25
Director/Board Member 58 2023-10-31
Director/Board Member 64 2020-07-30
Director/Board Member 68 2024-04-23
Director/Board Member - 2024-12-31
Composition of the Board of Directors

Shareholders: Bio-Techne Corporation

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.53 %
18,318,964 11.53 % 1 320 M $
BlackRock Advisors LLC
7.004 %
11,129,401 7.004 % 802 M $
T. Rowe Price International Ltd.
5.931 %
9,424,313 5.931 % 679 M $
6,395,993 4.025 % 461 M $
Eaton Vance Management
2.931 %
4,657,591 2.931 % 335 M $
List of BIO-TECHNE CORPORATION shareholders

Company details: Bio-Techne Corporation

Bio-Techne Corp.

614 McKinley Place NE

55413-2610, Minneapolis

+612 379 8854

http://www.bio-techne.com
address Bio-Techne Corporation(TECH)

Other Biotechnology & Medical Research

Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.32%+3.09%+11.34%-26.83%11.96B
0.00%+3.76%+37.04%-1.67%49.15B
+2.20%+4.05%-2.53%-15.98%37.29B
+1.51%+0.44%+3.85%+24.70%26.22B
-0.24%-2.87%-26.19%-26.62%16.22B
-0.12%+0.41%+64.57%+75.48%15.81B
-3.92%-18.10%-66.40%-79.38%13.46B
+1.64%+3.12%+19.29%+110.17%11.01B
-6.06%+13.64% - - 10.89B
-3.11%-4.65%-7.90%-19.58%9.46B
Average +0.06%+1.03%+3.68%+4.48% 20.15B
Weighted average by Cap. +0.40%+1.91%+9.46%+1.94%
See all sector performances
  1. Stock Market
  2. Equities
  3. TECH Stock
  4. Company Bio-Techne Corporation